Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

November 17, 2016November 17, 2016

MitoQ Antioxidant Lowers Oxidative Stress, Inflammation in Type 2 Diabetes Cells

News

The antioxidant MitoQ was seen to lower oxidative stress and inflammation in white blood cells from patients with type 2 diabetes. Since these factors are known contributors to heart disease, ... Read more

July 13, 2016July 13, 2016

Beneficial Effects of Relamorelin for Diabetes Stomach Problems Fail to Impress Several Experts

News

Rhythm Pharmaceuticals’ investigational drug relamorelin speeds up the passage of food through the stomach and reduces vomiting in adult patients with diabetic gastroparesis — a condition slowing the movement of ... Read more

June 10, 2016June 10, 2016

#EULAR2016 – Risk for Type 1 Diabetes Increases in Kids with Juvenile Inflammatory Arthritis, Study Shows

News

A study of more than 9,000 children found that patients with juvenile inflammatory arthritis more often develop type 1 diabetes than other children. Presented at the European League Against Rheumatism ... Read more

May 9, 2016September 6, 2016

Testosterone Receptor May Offer Way of Preventing Type 2 Diabetes in Hormone-Deficient Men

insulin resistance, News, Type 2 Diabetes News

Preventing testosterone signaling in pancreatic beta cells in mice leads to a higher insulin secretion in response to glucose, increasing the risk of type 2 diabetes, according to an article ... Read more

April 15, 2016April 15, 2016

Gene Found to Impact Type 1 Diabetes Autoimmune Processes

News

New research from Joslin Diabetes Center and Harvard Medical School have identified a gene that contributes to autoimmune processes in type 1 diabetes. While findings may have no imminent implications for ... Read more

April 6, 2016April 6, 2016

Hopes Raised for Potential Diabetes Treatments with Newly Discovered Immune Treg Cells

News, Type 1 Diabetes News

Researchers at The Scripps Research Institute in La Jolla, California, discovered a new type of immune cell that’s predisposed to become a regulatory T regulatory, or Treg cells, countering immune reactions. ... Read more

March 4, 2016March 4, 2016

In Diabetes Patients, IDegLira Combination Drug Superior in Controlling Glucose and Reducing Weight

insulin resistance, News, Type 2 Diabetes News

A clinical trial led by researchers at the UT Southwestern Medical Center revealed that IDegLira, a combination treatment with a new long-acting insulin, and liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, improves ... Read more

February 10, 2016February 10, 2016

Gene with Role in Type 2 Diabetes Found to Also Drive a Range of Psychiatric Ills

News, Type 2 Diabetes News

Type 2 diabetes is known to be more common in people with psychiatric disorders, such as depression, bipolar disorder and schizophrenia. Now, researchers at the Diabetes Center of Excellence at the University of Massachusetts Medical ... Read more

February 8, 2016February 9, 2016

Type 1 Diabetes Blocked in Mice Treated with New Compound, Nicknamed BBQ

News

In a breakthrough discovery, Oregon State University scientists have uncovered a compound with the ability to block the development of type 1 diabetes in mice by minimizing inflammation of the pancreatic ... Read more

February 2, 2016February 2, 2016

Mice Lacking Certain Gene Appear to Be Protected Against Effects of High-Fat Diet

News

An increased activity of brown fat in mice lacking the USF1 gene protects them from both arterial disease and becoming overweight – a finding that might be translated into new treatments ... Read more